Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
- Conditions
- Hand Dermatosis
- Interventions
- Other: Mild, moisturizing hand cleanser
- Registration Number
- NCT00843466
- Lead Sponsor
- Wake Forest University
- Brief Summary
The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).
- Detailed Description
The objective of this protocol is to evaluate compatibility and potential benefits of daily use of a marketed mild, moisturizing hand cleanser for subjects/patients who experience mild to moderate hand dermatitis induced by frequent cleansing.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
- Between 18 and 65 years of age
- In general good health
- Hands free of cuts and abrasions
- Agree to adhere to the requirements listed in the informed consent
- Willing and able to use a mild, moisturizing, non-antibacterial cleanser for all hand washing purposes for the duration of the test period
- Willing to refrain from participating in any other clinical research trial for the duration of the study
- Documented allergies to study product components, soaps, latex, or fragrances
- History of the following conditions which may affect the response of the skin or the interpretation of the results: insulin dependent diabetes, or peripheral vascular diseases
- Participating in a concurrent clinical study involving treatment of your hands
- Currently using a prescription medication for hand dermatitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mild moisturizing Hand Cleanser Mild, moisturizing hand cleanser The test group will be provided with a mild moisturizing hand cleanser for all hand cleansing needs during the duration of the study.
- Primary Outcome Measures
Name Time Method Investigator Global Assessment Wk 4 Changes in global disease severity on a scale from 0-4 with 0 being clear and 4 being severe
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Wake Forest University Health Sciences Dermatology
🇺🇸Winston-Salem, North Carolina, United States